Delhi AIIMS directs departments to analyse utilisation ratio of medical equipment by July 31

In line with good governance practices, it is important to have optimal control of inventory for all types of drugs and implants required at AIIMS, New Delhi to ensure zero unplanned procurement of the same via local purchase even for emergency / EHS patients, the memorandum issued by Dr Srinivas said.

Published On 2023-07-04 06:15 GMT   |   Update On 2023-07-04 06:15 GMT

New Delhi: In a move aimed at better use of medical equipment, the AIIMS administration on Monday asked its various departments to analyse the utilisation ratio of all medical and diagnostic equipment in their inventory by July 31 this year.

For the equipment whose utilization ratio is less than 0.5 (i.e. 50 per cent), an action plan shall be prepared to increase the utilization to at least 0.80 (i.e. 80 per cent), according to an office memorandum issued by AIIMS Director Dr M Srinivas on Monday.

Also Read:Delhi AIIMS to permit contractors from other PSUs to join tender process for engineering works

The director has taken rounds of various areas within AIIMS, and observed that few medical equipment are idling / underutilised and there is potential to increase their utility by sharing them with other departments, the memorandum said.

“Accordingly, it has been decided that all departments shall analyze the utilization ratio (i.e. the ratio of equipment utilized hours and the equipment hours available) for all medical and diagnostic equipment in their inventory by 31 July, 2023,” it said.

For cases, wherein the department is not able to develop a plan for effective utilization of any equipment in its inventory, it shall be reported to the office of the director for sharing / transferring the said equipment to another department where it may have better utilization.

In another office memorandum, the administration has sought minimizing local purchase of drugs and implants, stressing that efforts should be made to target “zero local purchase” for any non-emergent requirements.

In line with good governance practices, it is important to have optimal control of inventory for all types of drugs and implants required at AIIMS, New Delhi to ensure zero unplanned procurement of the same via local purchase even for emergency / EHS patients, the memorandum issued by Dr Srinivas said.

“In continuation of earlier office memorandums dated November 3, 2022, and December 15, 2022, on the issue, it is reiterated that procurement via local purchase system should only be rarely done for emergent requirements of patients/EHS. All efforts should be made to target ‘zero local purchase’ for any non-emergent requirements,” it said.

In case of non-emergent procurement of any drugs due to expiry of rate contract, a comparison should be done by the procuring store between the price offered rate contracted vendor, LP chemist, AMRIT, Jan Aushadhi store, etc, and the procurement shall be done from the source offering the lowest price.

“To minimize local purchase, heads of departments shall on an annual basis send the list of medicines and consumables to the Medical Superintendent by 31st December which are beyond standard hospital formulary but are required for patients admitted under the care of their respective departments. “For all such additional medicines and consumables, Hospital Store shall execute rate contracts by 31st March as is done for items in the Hospital Formulary or procure them via AMRIT / Jan Aushadhi store,” the memorandum said.

Further, it shall be ensured that AMRIT stores at AIIMS New Delhi keep stock of all required medicines, stents and implants and the same is available to patients on 24×7 basis, it said.

Also Read:AlIMS Delhi sets up committee to streamline hospital staff official travel needs

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News